Humphreys E R, Loutit J F, Stones V A
Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Feb;51(2):331-9. doi: 10.1080/09553008714550801.
Plutonium-239 was injected into 12-week-old female CBA/H mice in the range 1.85-18.5 kBq kg-1 either as a single injection or as 16 injections spaced at 3.5 day intervals over eight weeks. There was a highly significant increase in the yield of fully developed osteosarcomas with increased amounts of 239Pu for both modes of injection. Osteosarcomas too small to be diagnosed radiographically were also seen in many bones and small but significant yields of myeloid leukaemia were seen in animals given plutonium. Although more myeloid leukaemia was seen in the mice given plutonium in divided amounts than in those given the plutonium in a single injection it could not be shown that multiple injection significantly affected the yield of either late effect.
将钚 - 239以1.85 - 18.5 kBq kg⁻¹的剂量注射到12周龄的雌性CBA/H小鼠体内,注射方式分为单次注射或在八周内每隔3.5天注射一次,共注射16次。对于两种注射方式,随着239Pu剂量的增加,完全发育的骨肉瘤产量均有极显著增加。在许多骨骼中还发现了因体积过小而无法通过放射学诊断的骨肉瘤,并且在接受钚注射的动物中观察到了少量但显著的髓系白血病发生率。尽管分次注射钚的小鼠比单次注射钚的小鼠出现了更多的髓系白血病,但无法证明多次注射会显著影响这两种晚期效应的发生率。